Details of the Drug

General Information of Drug (ID: DMB6L97)

Drug Name

GSK-2202083A

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01090453) Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants. U.S. National Institutes of Health.